Skip to main content

Published locations for PsA: Ixekizumab more effective than adalimumab irrespective of concomitant psoriasis severity

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PsA: Ixekizumab more effective than adalimumab irrespective of concomitant psoriasis severity

User login

  • Reset your password
  • /content/psa-ixekizumab-more-effective-adalimumab-irrespective-concomitant-psoriasis-severity
  • /dermatology/article/249249/psoriatic-arthritis/psa-ixekizumab-more-effective-adalimumab-irrespective
  • /psoriatic-arthritis-icymi/article/249249/psoriatic-arthritis/psa-ixekizumab-more-effective